Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study (Repeated Administrations of Oxytocin in Infants With Prader Willi Syndrome Aged From 0 to 6 Months) and Comparison With Not Treated and Age-matched Prader Willi Syndrome Infants (OT2SUITE)
Latest Information Update: 01 Apr 2026
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Acronyms OT2SUITE
Most Recent Events
- 01 Apr 2026 New trial record